Syndax Pharmaceuticals Inc (SNDX)
Operating Cash Flow Growth
65.52%
Quarterly · Period ending:
SNDX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported65.52%period ending
Latest reported65.52%period ending
SNDX Quarterly Cash from Operations YoY % (-258679.34% → 65.52%)
Year-over-year change
High-resolution chart · PNG
SNDX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 65.5197% | |
| 47.0955% | |
| -21.0845% | |
| -13.1783% | |
| -22.5417% | |
| -13.901% | |
| -38.7893% | |
| -39.5696% | |
| -102.5529% | |
| -112.9805% | |
| -80.6106% | |
| -56.4357% | |
| 12.2438% | |
| 6.4463% | |
| -122.7328% | |
| -14.4323% | |
| -67.6274% | |
| -85.6257% | |
| 744.2902% | |
| -36.3284% | |
| -12.3231% | |
| -41.8462% | |
| -22.8176% | |
| -114.5269% | |
| -70.9142% | |
| 5.3829% | |
| 15.3959% | |
| 53.8199% | |
| 17.3213% | |
| 15.2944% | |
| -18.244% | |
| -81.4065% | |
| -28.3814% | |
| -56.8519% | |
| -22.139% | |
| 11.0674% | |
| -71.2627% | |
| -97.8448% | |
| -142.5146% | |
| -120.9186% | |
| -72.4224% | |
| -157.9719% | |
| -23.5971% | |
| -99.1545% | |
| -5.0473% | |
| 344.7917% | |
| -26.0885% | |
| -22.3319% | |
| -310.356% | |
| -203.8384% | |
| -258,679.3427% |